Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.
作者信息
Lennard-Jones J E
出版信息
Gut. 1983 Mar;24(3):177-81. doi: 10.1136/gut.24.3.177.
Abstract
摘要
相似文献
1
Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.实现溃疡性结肠炎和克罗恩病中皮质类固醇的最佳使用。
Gut. 1983 Mar;24(3):177-81. doi: 10.1136/gut.24.3.177.
2
Corticosteroids for the management of ulcerative colitis and Crohn's disease.
Gastroenterol Clin North Am. 1989 Mar;18(1):21-34.
3
[Corticosteroids in gastroenterology].[胃肠病学中的皮质类固醇]
Ned Tijdschr Geneeskd. 1978 Mar 25;122(12):406-10.
4
Current status of drug therapy for inflammatory bowel disease.炎症性肠病药物治疗的现状
Compr Ther. 1985 Dec;11(12):14-9.
5
[Conservative therapy of ulcerative colitis and Crohn disease].溃疡性结肠炎和克罗恩病的保守治疗
Fortschr Med. 1991 Apr 10;109(11):245-7.
6
The drug therapy of ulcerative colitis and of Crohn's disease.
Semin Drug Treat. 1974 Spring;3(4):339-49.
7
[New treatments for ulcerative colitis and Crohn's disease].[溃疡性结肠炎和克罗恩病的新疗法]
Nihon Shokakibyo Gakkai Zasshi. 1989 Sep;86(9):2323-62.
8
9
Medical treatment of ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病的医学治疗。
J Clin Hosp Pharm. 1983 Sep;8(3):219-32.
10
Maintenance therapy in ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病的维持治疗。
J Clin Gastroenterol. 1995 Mar;20(2):117-22. doi: 10.1097/00004836-199503000-00009.
引用本文的文献
1
Second United Arab Emirates consensus guidance on the diagnosis and management of inflammatory bowel disease.阿联酋关于炎症性肠病诊断与管理的第二项共识指南。
World J Gastroenterol. 2025 Sep 21;31(35):109882. doi: 10.3748/wjg.v31.i35.109882.
2
Long-term efficacy of mesenchymal stem cell treatment for complex perianal fistulas: A systematic review and meta-analysis.间充质干细胞治疗复杂性肛瘘的长期疗效：一项系统评价和荟萃分析。
Cent Eur J Immunol. 2024;49(3):273-281. doi: 10.5114/ceji.2024.144866. Epub 2024 Nov 12.
3
Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.肛周瘘管性克罗恩病：发病机制、诊断与治疗。
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):652-664. doi: 10.1038/nrgastro.2017.104. Epub 2017 Aug 9.
4
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.炎症性肠病中肠可溶性介质的治疗前后评估：我们的现状和未来展望。
Mediators Inflamm. 2013;2013:391473. doi: 10.1155/2013/391473. Epub 2013 May 8.
5
Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis.内镜检查结果可预测白细胞去除术对未使用过类固醇的中度活动性溃疡性结肠炎患者的疗效。
World J Gastroenterol. 2008 Sep 14;14(34):5316-21. doi: 10.3748/wjg.14.5316.
6
Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process.皮质类固醇抑制炎症介质的产生是一个糖皮质激素受体介导的过程。
Mediators Inflamm. 1996;5(2):100-3. doi: 10.1155/S0962935196000166.
7
Frequency of glucocorticoid resistance and dependency in Crohn's disease.克罗恩病中糖皮质激素抵抗和依赖的发生率
Gut. 1994 Mar;35(3):360-2. doi: 10.1136/gut.35.3.360.
8
Steroids: a surgeon's view.类固醇：一位外科医生的观点。
Arch Emerg Med. 1985 Sep;2(3):131-6. doi: 10.1136/emj.2.3.131.
9
Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.用于治疗炎症性肠病的药物的风险效益评估。
Drug Saf. 1991 May-Jun;6(3):192-219. doi: 10.2165/00002018-199106030-00005.
10
The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation.
Ann Surg. 1992 Jun;215(6):598-603; discussion 604-5. doi: 10.1097/00000658-199206000-00006.
本文引用的文献
1
PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION.泼尼松作为溃疡性结肠炎缓解期的维持治疗药物。
Lancet. 1965 Jan 23;1(7378):188-9. doi: 10.1016/s0140-6736(65)90973-6.
2
Out-patient treatment of ulcerative colitis. Comparison between three doses of oral prednisone.溃疡性结肠炎的门诊治疗。三种剂量口服泼尼松的比较。
Br Med J. 1962 Aug 18;2(5302):441-3. doi: 10.1136/bmj.2.5302.441.
3
Cortisone in ulcerative colitis; final report on a therapeutic trial.可的松治疗溃疡性结肠炎；一项治疗试验的最终报告
Br Med J. 1955 Oct 29;2(4947):1041-8. doi: 10.1136/bmj.2.4947.1041.
4
Pharmacokinetics of intravenous and oral prednisolone.静脉注射和口服泼尼松龙的药代动力学
Br J Clin Pharmacol. 1980 Nov;10(5):503-8. doi: 10.1111/j.1365-2125.1980.tb01796.x.
5
Rectally administered prednisolone--evidence for a predominantly local action.直肠给药的泼尼松龙——主要为局部作用的证据。
Gut. 1980 Mar;21(3):215-8. doi: 10.1136/gut.21.3.215.
6
Prednisolone absorption in acute colitis.急性结肠炎中泼尼松龙的吸收情况。
Gut. 1980 Jan;21(1):49-51. doi: 10.1136/gut.21.1.49.
7
Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration.口服泼尼松龙后克罗恩病和乳糜泻患者的血清泼尼松龙水平。
Digestion. 1981;21(6):310-5. doi: 10.1159/000198583.
8
Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.泼尼松龙对溃疡性结肠炎直肠黏膜前列腺素合成的影响：通过层流生物测定法和放射免疫测定法进行的研究。
Gut. 1981 Mar;22(3):190-3. doi: 10.1136/gut.22.3.190.
9
Plasma prednisolone levels during intravenous therapy in acute colitis.急性结肠炎静脉治疗期间的血浆泼尼松龙水平。
Gut. 1982 Nov;23(11):980-83. doi: 10.1136/gut.23.11.980.
10
A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission.一项关于隔日使用泼尼松龙作为溃疡性结肠炎缓解期维持治疗的对照试验。
Digestion. 1981;22(5):263-70. doi: 10.1159/000198667.
Zotero 插件